Eligo Bioscience, a pioneering gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.
Rainbird Technologies and Klick Health today announced an exclusive, new partnership that will bring Rainbird’s proven Decision Intelligence platform to life sciences companies across North America, reinforcing both companies’ success working in highly regulated industries.
Artificial Intelligence (AI)-driven Primary Care company K Health announces today the publication of its peer-reviewed research in Mayo Clinic Proceedings: Digital Health, which demonstrates how K Health’s AI can provide information that allows for more personalized hypertension treatment in patient-facing settings.
Lightning Step, a leading provider of All-In-One CRM, EMR, and RCM solutions for behavioral health and addiction treatment facilities, is enhancing its platform with vital recovery support and alumni engagement for those contending with Substance Use Disorder (SUD).
First-of-its-Kind Study will Use FDA-Cleared Wearable Technology to Better Understand and Predict SeizuresBOSTON--(BUSINESS WIRE)--Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitorin...
Through Commure Engage, Yale New Haven Health Automates Personalized Patient Outreach, Boosts Rates of Breast Cancer ScreeningsSAN FRANCISCO--(BUSINESS WIRE)--#commure--Commure Engage (formerly known as Rx.Health), a leading digital health and clinica...
GE HealthCare announced an industry-first US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax (PTX) algorithm for the detection, notification, triage and diagnosis of PTX.
RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, is proud to announce major milestones in advancing its industry-leading deep clinical AI.
The quest to eliminate lung cancer as a global cause of death has taken a positive step forward with 1 million-milestone met of a 5-million lung health Artificial Intelligence (AI) commitment. This new proactive initiative casts a wider net to currently invisible and unprofiled global patient populations, innovating beyond traditional lung cancer screening profiles such as age and smoking history.
Laudio, an innovator in frontline leader solutions that drive efficiency and engagement for health systems, today announced that Memorial Hermann Health System is implementing Laudio’s platform to enhance employee efficiency and engagement.